Aigen Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17,773
| Closed | -$568K | – | 819 |
|
|
2022
Q2 | $568K | Buy |
+17,773
| New | +$568K | 0.1% | 280 |
|
|
2021
Q3 | – | Sell |
-11,432
| Closed | -$400K | – | 714 |
|
|
2021
Q2 | $400K | Buy |
+11,432
| New | +$400K | 0.07% | 269 |
|
|
2021
Q1 | – | Sell |
-16,796
| Closed | -$727K | – | 962 |
|
|
2020
Q4 | $727K | Buy |
+16,796
| New | +$727K | 0.09% | 284 |
|
|
2020
Q1 | – | Sell |
-164
| Closed | -$13K | – | 1663 |
|
|
2019
Q4 | $13K | Buy |
+164
| New | +$13K | ﹤0.01% | 954 |
|